Comparison of two RT-PCR methods for quantifyingampCspecific transcripts inEscherichia colistrains
Open Access
- 1 November 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 228 (2) , 187-191
Abstract
In Escherichia coli, β-lactam resistance usually depends on β-lactamase production. AmpC chromosomal cephalosporinase hyperproduction is generally due to mutations in the ampC gene promoter. In order to study ampC expression in E. coli clinical strains, we have compared two methods: conventional and real-time reverse transcription-polymerase chain reaction (RT-PCR). With both methods, ampC mRNA was found to be greatly increased in strains presenting —42 or —32 mutations in the ampC promoter, and moderately increased when a —11 mutation was present in the Pribnow box. Real-time RT-PCR represents a powerful tool combining amplification, fluorescent detection and analysis.Keywords
This publication has 27 references indexed in Scilit:
- −11 Mutation in theampCPromoter Increasing Resistance to β-Lactams in a ClinicalEscherichia coliStrainAntimicrobial Agents and Chemotherapy, 2002
- Broad Resistance Due to Plasmid‐Mediated AmpC β‐Lactamases in Clinical Isolates ofEscherichia coliClinical Infectious Diseases, 2002
- Comparison of Different Approaches To Quantify Staphylococcus aureus Cells by Real-Time Quantitative PCR and Application of This Technique for Examination of CheeseApplied and Environmental Microbiology, 2001
- Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing AmpCJournal of Antimicrobial Chemotherapy, 2000
- Quantification of Clostridium botulinum Toxin Gene Expression by Competitive Reverse Transcription-PCRApplied and Environmental Microbiology, 2000
- Direct Quantitative Transcript Analysis of the agr Regulon of Staphylococcus aureus during Human Infection in Comparison to the Expression Profile In VitroInfection and Immunity, 2000
- Molecular Basis of AmpC Hyperproduction in Clinical Isolates of Escherichia coliAntimicrobial Agents and Chemotherapy, 1999
- Compilation and analysis ofEscherichia colipromoter DNA sequencesNucleic Acids Research, 1983
- ampC cephalosporinase of Escherichia coli K-12 has a different evolutionary origin from that of beta-lactamases of the penicillinase type.Proceedings of the National Academy of Sciences, 1981
- Isolation and characterization of DNA repetitions carrying the chromosomal β-lactamase gene of Escherichia coli K-12Molecular Genetics and Genomics, 1979